Cerastatin, a new potent inhibitor of platelet aggregation from the venom of the Tunisian viper, Cerastes cerastes

Toxicon

Volumn 35, Issue 1, 1997, Pages 125-135

  Marrakchi, Naziha ^a,b   Barbouche, Rym ^a   Bon, Cassian ^c   El Ayeb, Mohamed ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CERASTATIN; FIBRINOGEN RECEPTOR; UNCLASSIFIED DRUG; VIPER VENOM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALS; CHYMOTRYPSIN; CLOT RETRACTION; FEMALE; GLYCOPROTEINS; MALE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RABBITS; VIPER VENOMS;

EID: 0031018096     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(96)00020-7     Document Type: Article

References (32)

1. Ardlie, N. G., Pakham, M. A. and Mustard, J. F. (1970) Adenosine diphosphate-induced platelet aggregation in suspension of washed rabbit platelets. Br. J. Haemat. 19, 7-16.
2. Blobel, C. P., Wolfsberg, T. G., Turck, C. W., Myles, D. G., Primakoff, P. and White, J. M. (1992) A potentiel fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 356, 248-252.
3. Born, G. V. R. (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194, 927-929.
4. Colman, R. W. and Walsh P. N. (1987) In Hemostasis and Thrombosis: Basic Principles and Clinical Practice, ed. Colman, R. W., Hirsch, I., Marder, V. J. and Salzman, E. W., pp. 594-605. J. B. Lippincott Company, Philadelphia, PA, U.S.A.
5. 2 activity by colorimetric assay using a pH indicator. Toxicon 25, 1181-1188.
6. Dennis, M. S., Henzel, W. J., Pitti, R. M., Lipari, M. T., Napier, M. A., Deisher, T. A., Bunting, S. and Lazarus, R. A. (1990) Platelet glycoprotein antagonists from snake venomes: evidence for a family of platelet aggregation inhibitors. Proc. natl Acad. Sci. U.S.A. 87, 2471-2475.
7. Di Minno, G., Thiagarajan, P., Perrussia, B., Martinez, J., Shapiro, S., Trinchieri, G. and Murphy, S. (1983) Exposure of platelet fibrinogen binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIa complex. Blood 61, 140-148.
8. D'Souza, S. E., Ginsberg, M. H. and Plow, E. F. (1991) Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. Trends biochem. Sci. 16, 246-250.
9. Gartner, T. K. and Bennett, J. S. (1985) The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J. biol. Chem. 260, 11891-11894.
10. Gould, R. J., Polokoff, M. A., Friedman, P. A., Huang, T. F., Holt, J. C., Cook, J. J. and Nieawarowski, S. (1990) Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc. Soc. exp. Biol. Med. 195, 168-171.
11. Greenberg, J. P., Packham, M. A., Guccione, M. A., Harfenist, E. J., Orr, J. L., Greenberg, J. P., Packham, M. A., Guccione, M. A., Harpenist, E. J., Orr, J. L., Kinlough-Rathbone, R. L., Perry, D. W. and Mustard, J. F. (1990) The effect of pretreatment of human or rabbit platelets is independent of ADP release. Blood 54, 753-765.
12. Harfenist, E. F., Guccione, M. A., Packham, M. A., Kinlough-Rathbone, R. L. and Mustard, J. F. (1982) Arachidonate-induced fibrinogen binding to thrombin degranulated rabbit platelets is independent of released ADP. Blood 59, 956-962.
13. Hawiger, J., Parkinson, S. and Timmons, S. (1980) Prostacyclin inhibits mobilisation of fibrinogen binding sites on human ADP and thrombin treated platelets. Nature 283, 195-197.
14. Huang, T. F., Wu, Y. J. and Ouyang, C. (1987) Characterization of a potent platelet aggregation inhibitor from Agkistroden rhodostoma snake venom. Biochem. biophys. Acta 925, 248-257.
15. Kini, R. M. and Evans, H. J. (1992) Structural domains in venom proteins: evidence that metalloproteinase and non enzymatic platelet aggregation inhibitors (disintegrins) from sanke venoms are derived by proteolysis from a common precursor. Toxicon 30, 265-293.
16. Kloczewiak, M., Timmons, S., Lukas, T. J. and Hawiger. J. (1984) Platelet receptor recognition site on human fibrinogen: synthesis and structure-function relationship of peptides corresponding to the carboxyterminal segment. Biochemistry 23, 1767-1774.
17. Kloczewiak, M., Timmons, S., Bednarek, A., Sakon, M. and Hawiger, J. (1989) Platelet receptor recognition domain on the γ chain of human fibrinogen and its synthetic peptide analogues. Biochemistry 28, 2915-2919.
18. Marguerie, G. A., Plow, E. F. and Edgington, T. S. (1979) Human platelet possesses an inductible and saturable receptor specific for fibrinogen. J. biol. Chem. 254, 5357-5363.
19. Mazur, P., Dennis, M. S., Seymour, J. L. and Lazarus, R. A. (1991) Expression, purification, and characterization of recombinant ornatin E, a potent glycoprotein IIb-IIIa antagonist. Protein Express. Purif. 4, 282-289.
20. Ouyang, C., Hwang, L. J. and Huang, T. F. (1983) α-Fibrinogenase from Agkistrodon rhodostoma (Malayan pit viper) snake venom. Toxicon 21, 25-33.
21. Ouyang, C., Hwang, L. J. and Huang, T. F. (1985) Inhibition of rabbit platelet aggregation by fibrinogenase-purified from Agkistrodon rhodostoma (Malayan pit viper) snake venom. J. Formosan Med. Ass. 84, 1196-1206.
22. Ouyang, C., Yeh, H. I. and Huang, T. F. (1986) Purification and characterization of a platelet aggregation inducer by α-fibrinogenase purified from Calloselesma rhodostoma (Malayan pit viper) snake venom. Toxicon 24, 633-643.
23. Peerschke, E. I., Zucker, M. B., Grant, R. A., Egan, J. J. and Johnson, M. M. (1980) Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood 55, 841-847.
24. Plow, E. F. and Marguerie, G. A. (1980a) Participation and ADP in the binding of fibrinogen to thrombin stimulated platelets. Blood 56, 553-555.
25. Plow, E. F. and Marguerie, G. A. (1980b) Induction of the fibrinogen on human platelets by epinephrin and the combination of epinephrine and ADP. J. biol. Chem. 255, 10971-10977.
26. Plow, E. F., Pierschbahcer, M. D., Ruoslahti, E., Marguerie, G. A. and Ginsbergh, M. H. (1985) The effect of Arg-Gly-Asp containing peptides on fibrinogen and von willebrand factor binding to platelets. Proc. natn. Acad. Sci. U.S.A. 82, 8057-8061.
27. Roberts, P. S. (1958) Measurements of the rate of plasmin action on synthetic substrates. J. biol. Chem. 232, 285-291.
28. Scarborough, R. M., Rose, J. W., Hsu, M. A., Phillips, D. R., Fried, V. A., Campbell, A. M., Nannizzi, L. and Charo, I. F. (1991) Barbourin. A GPIIb-IIIa specific integrin antagonist from the venom of Sistrurus barbouri. J. biol. Chem. 266, 9359-9362.
29. Scarborough, R. M., Naughton, M. A., Teng, W., Rose, J. W., Phillips, D. R., Nannizzi, L., Arfsten, A., Campbell, A. M. and Charo, I. F. (1993) Design of potent and specific integrin antagonists. J. biol. Chem. 268, 1066-1073.
30. Seymour, J. L., Henzel, W. J., Nevins, B., Stults, J. T. and Lazarus, R. A. (1990) Decorsin, a potent glycoprotein Ub-IIIa antagonist and platelet aggregation inhibitor from the leech Marcobdella decora. J. biol. Chem. 265, 10143-10147.
31. Van Seuningen, I. and Davril, M. (1992) A rapid periodic acid Schiff staining procedure for the detection of glycoproteins using the Phast system. Electrophoresis 13, 97-99.
32. Zingali, L. R., Jandrot-Perrus, M., Guillin, M. C. and Bon, C. (1993) Bothrojaracin. A new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition. Biochemistry 32, 1079-1082.